晚期乳腺癌的化疗：环磷酰胺与四联药物组合的对照随机试验。
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.
作者信息
Rubens R D, Knight R K, Hayward J L
出版信息
Br J Cancer. 1975 Dec;32(6):730-6. doi: 10.1038/bjc.1975.284.
Abstract
Ninety-nine patients with advanced breast cancer were randomized to receive either cyclophosphamide continuously or a combination of cyclophosphamide, methotrexate, 5-fluorouracil and vinblastine given intermittently. The number and duration of objective responses were greater in patients receiving the combination but the differences between the two treatments did not achieve formal significance. The combination was logistically easier to manage and produced less toxicity.
摘要
99例晚期乳腺癌患者被随机分组，分别接受持续环磷酰胺治疗或环磷酰胺、甲氨蝶呤、5-氟尿嘧啶和长春花碱间歇联合治疗。接受联合治疗的患者客观缓解的数量和持续时间更多，但两种治疗方法之间的差异未达到统计学显著性。联合治疗在组织实施上更易管理，且毒性更小。
相似文献
1
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.晚期乳腺癌的化疗：环磷酰胺与四联药物组合的对照随机试验。
Br J Cancer. 1975 Dec;32(6):730-6. doi: 10.1038/bjc.1975.284.
2
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
Cancer Treat Rep. 1977 Jan-Feb;61(1):47-50.
3
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.阿霉素与甲氨蝶呤联合药物治疗的随机对照试验。
Cancer. 1978 May;41(5):1649-57. doi: 10.1002/1097-0142(197805)41:5<1649::aid-cncr2820410501>3.0.co;2-j.
4
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.绝经后女性转移性乳腺癌的化疗：环磷酰胺与环磷酰胺、长春新碱、甲氨蝶呤、5-氟尿嘧啶和泼尼松五药联合方案的对照试验
Prog Clin Biol Res. 1977;12:459-66.
5
6
Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Arch Intern Med. 1977 Dec;137(12):1711-4.
7
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Cancer Clin Trials. 1981 Winter;4(4):363-9.
8
[Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].[联合抗代谢药-烷化剂-长春碱治疗晚期乳腺癌]
Minerva Med. 1977 Mar 17;68(13):835-7.
9
Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.晚期乳腺癌的五药联合疗法：影响毒性和反应的因素
Cancer. 1974 Aug;34(2):239-45. doi: 10.1002/1097-0142(197408)34:2<239::aid-cncr2820340202>3.0.co;2-e.
10
Combination chemotherapy in metastatic carcinoma of the breast. Results with a three-drug combination.转移性乳腺癌的联合化疗。三药联合治疗的结果。
Cancer. 1975 Aug;36(2):311-7. doi: 10.1002/1097-0142(197508)36:2<311::aid-cncr2820360204>3.0.co;2-i.
引用本文的文献
1
Single agent versus combination chemotherapy for metastatic breast cancer.转移性乳腺癌的单药化疗与联合化疗
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3.
2
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.多西他赛联合环磷酰胺作为转移性乳腺癌一线化疗的I期研究。
Br J Cancer. 2002 Nov 4;87(10):1072-8. doi: 10.1038/sj.bjc.6600626.
3
Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.雌激素受体与晚期乳腺癌对细胞毒性化疗的反应
Cancer Chemother Pharmacol. 1980;4(1):43-5. doi: 10.1007/BF00255457.
4
Chemotherapy of breast cancer.乳腺癌的化疗
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
5
Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?
Breast Cancer Res Treat. 1983;3(2):117-27. doi: 10.1007/BF01803554.
6
Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group.晚期乳腺癌联合化疗与序贯单药化疗：与转移部位及长期生存的关联。西部癌症研究组和东南部癌症研究组。
Br J Cancer. 1989 Feb;59(2):227-30. doi: 10.1038/bjc.1989.46.
7
Systemic therapy of advanced breast cancer.晚期乳腺癌的全身治疗
Drugs. 1992;44 Suppl 4:17-28; discussion 66-9. doi: 10.2165/00003495-199200444-00003.
本文引用的文献
1
Combination chemotherapy in the treatment of advanced Hodgkin's disease.联合化疗治疗晚期霍奇金病
Ann Intern Med. 1970 Dec;73(6):881-95. doi: 10.7326/0003-4819-73-6-881.
2
Cyclical combination chemotherapy for advanced breast carcinoma.晚期乳腺癌的周期性联合化疗
Br Med J. 1974 Feb 9;1(5901):218-20. doi: 10.1136/bmj.1.5901.218.
3
Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer.会议论文：联合与序贯细胞毒性化疗在晚期乳腺癌治疗中的评估
Cancer. 1974 Feb;33(2):513-8. doi: 10.1002/1097-0142(197402)33:2<513::aid-cncr2820330228>3.0.co;2-h.
4
Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.
Cancer Chemother Rep. 1974 Mar-Apr;58(2):251-3.
5
Adriamycin. A new anticancer drug with significant clinical activity.阿霉素。一种具有显著临床活性的新型抗癌药物。
Ann Intern Med. 1974 Feb;80(2):249-59. doi: 10.7326/0003-4819-80-2-249.
6
Single and combination nonhormonal chemotherapy in breast cancer.乳腺癌的单药及联合非激素化疗
Cancer. 1972 Dec;30(6):1543-55. doi: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v.
7
Ten years' experience of sterioid assays in the management of breast cancer. A review.
Lancet. 1968 Dec 14;2(7581):1255-60. doi: 10.1016/s0140-6736(68)91757-1.
8
Combination cancer therapy: Presidential address.联合癌症治疗：主席致辞
Cancer Res. 1972 Dec;32(12):2593-607.
9
L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.左旋苯丙氨酸氮芥（L-PAM）用于原发性乳腺癌的治疗。早期研究结果报告。
N Engl J Med. 1975 Jan 16;292(3):117-22. doi: 10.1056/NEJM197501162920301.
Zotero 插件